Why the study?
Does reimplantation of the aortic valve (RAV) reduce in-hospital mortality and improve long-term outcomes compared to composite valve graft (CVG) in patients with Marfan syndrome?
Population
2156 patients with Marfan syndrome pooled from 20 retrospective studies with long-term follow-up
Comparison
Reimplantation of the aortic valve / David… vs Composite valve graft (CVG) / Bentall procedure
Design
Meta-analysis
Follow-up
long-term
Authors
Loading...
May favor RAV over CVG when feasible in Marfan patients; leaves open need for randomized confirmation before changing practice.
Does reimplantation of the aortic valve (RAV) reduce in-hospital mortality and improve long-term outcomes compared to composite valve graft (CVG) in patients with Marfan syndrome?
The reimplantation of the aortic valve (David procedure) significantly reduces in-hospital mortality and improves long-term survival and freedom from reintervention compared to the composite valve graft (Bentall procedure) in patients with Marfan syndrome.
Burgstaller et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: